 <p><b>Allergy Testing Access Act of </b><b>2021</b></p> <p>This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. </p> <p>Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.</p>